Theseus Pharmaceuticals (THRX) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free THRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTheseus Pharmaceuticals Announces Closing of Tender Offerfinance.yahoo.com - February 14 at 12:58 PMTheseus Pharmaceuticals Announces Closing of Tender Offerprnewswire.com - February 14 at 8:30 AMmarketbeat.com - February 14 at 6:08 AMConcentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticalsfinance.yahoo.com - January 30 at 8:42 AMSHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CSTR, THRX, GRCL, ROVRstockhouse.com - January 20 at 12:33 PMShort Interest in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Drops By 37.4%marketbeat.com - January 13 at 7:54 AMTHESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ...businesswire.com - December 31 at 7:22 PMIs Theseus Pharmaceuticals (THRX) Stock a Solid Choice Right Now?finance.yahoo.com - December 29 at 2:45 PMTheseus Pharmaceuticals, Inc. (NASDAQ:THRX) Short Interest Updatemarketbeat.com - December 29 at 8:55 AMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX, CONNmarkets.businessinsider.com - December 27 at 6:52 PMTheseus Pharmaceuticals Shares Rise 9.3% on Deal to Be Acquired by Concentramarketwatch.com - December 22 at 2:11 PMConcentra Biosciences to Acquire Theseus Pharmaceuticals for $3.90 to $4.05/Shrmarketwatch.com - December 22 at 9:11 AMTheseus Pharma To Acquire Concentra Biosciences For $4.05/Shr In Cashmarkets.businessinsider.com - December 22 at 9:11 AMTHRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholderstmcnet.com - December 22 at 9:11 AMTheseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Rightfinance.yahoo.com - December 22 at 9:11 AMUP Fintech, Cerence, Irsa Inversiones Y Representaciones among premarket gainers packmsn.com - November 27 at 9:13 AMTheseus Pharma To Evaluate Expression Of Interest From Foresite, OrbiM And Proposal From Concentramarkets.businessinsider.com - November 27 at 9:13 AMTheseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLCfinance.yahoo.com - November 27 at 9:13 AMTheseus Pharmaceuticals Inc (THRX) Explores Strategic Alternatives Amidst Workforce Reductionfinance.yahoo.com - November 14 at 10:47 PMTwo years after IPO, Theseus Pharmaceuticals lays off most its staff, explores salebizjournals.com - November 14 at 5:47 PMThinking about buying stock in Theseus Pharmaceuticals, Vuzix, Jaguar Global Growth, Fisker, or Cardio Diagnostics Holdings?benzinga.com - November 14 at 12:47 PMTheseus Pharmaceuticals Shares Rise 35% on Workforce Reduction, Strategic Alternatives Considerationmarketwatch.com - November 13 at 8:30 PMTheseus Pharmaceuticals explores strategic options; cuts workforce by 72%msn.com - November 13 at 8:30 PMTheseus Pharmaceuticals Announces Process to Explore Strategic Alternativesfinance.yahoo.com - November 13 at 8:30 PMmarketbeat.com - November 13 at 4:06 PMTheseus Pharmaceuticals Inc THRXmorningstar.com - November 7 at 10:32 PMTheseus Pharmaceuticals to Participate in the Stifel 2023 Healthcare Conferencefinance.yahoo.com - November 7 at 5:32 PMTheseus Pharmaceuticals (NASDAQ:THRX) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - October 9 at 4:04 PMTheseus Pharmaceuticals: Picking Up The Pieces After A Lead Failuremsn.com - September 29 at 8:41 AMTheseus Pharmaceuticals, Inc. Expected to Earn Q3 2023 Earnings of ($0.37) Per Share (NASDAQ:THRX)marketbeat.com - August 14 at 1:21 AMDown -65.65% in 4 Weeks, Here's Why You Should You Buy the Dip in Theseus Pharmaceuticals, Inc. (THRX)finance.yahoo.com - August 11 at 7:00 PMTheseus Pharmaceuticals, Inc. (NASDAQ:THRX) Expected to Post Q1 2024 Earnings of ($0.33) Per Sharemarketbeat.com - August 11 at 11:05 AMDeciphera Pharmaceuticals Sees Renewed Competitive Edge After Theseus Pan-KIT Discontinuation: Analystmarkets.businessinsider.com - August 10 at 6:27 PMTheseus Pharmaceuticals Announces Business Highlights and Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 10 at 8:26 AMTheseus Pharmaceuticals Recent Insider Activitybenzinga.com - July 21 at 6:51 PMMassive Insider Trade At Theseus Pharmaceuticalsbenzinga.com - July 20 at 3:12 PMDirector of Theseus Pharmaceuticals Makes $1.46M Buybenzinga.com - July 20 at 3:12 PMAfter Plunging -69.57% in 4 Weeks, Here's Why the Trend Might Reverse for Theseus Pharmaceuticals, Inc. (THRX)finance.yahoo.com - July 18 at 3:43 PMThinking about buying stock in AMC Entertainment, Archer Aviation, Theseus Pharmaceuticals, Quantumscape, or Acumen Pharmaceuticals?benzinga.com - July 17 at 12:35 PMTheseus (THRX) Falls 72% on Decision to Discontinue GIST Studymsn.com - July 17 at 12:35 PMTheseus Pharma Shares Fall 71%, Company Halts Development of Tumor Drug THE-630 in Patients with GISTmarketwatch.com - July 14 at 3:43 PMSetback For Theseus Pharmaceuticals: Analysts Cut Price Targets But Remain Bullish On Stockmarkets.businessinsider.com - July 14 at 3:43 PMTheseus Pharmaceuticals (NASDAQ:THRX) Price Target Lowered to $7.00 at Cantor Fitzgeraldmarketbeat.com - July 14 at 10:27 AMWhy Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarketmsn.com - July 14 at 10:12 AMTHRX Tanks after Pausing Trial of Lead Cancer Candidatemsn.com - July 14 at 10:12 AMDose-Limiting Toxicities: Theseus Pharma Terminates THE-630 Study For Gastrointestinal Cancermarkets.businessinsider.com - July 14 at 10:12 AMAnalyst Expectations for Theseus Pharmaceuticals's Futuremarkets.businessinsider.com - July 14 at 10:12 AMTheseus Pharmaceuticals Terminates Development Of THE-630markets.businessinsider.com - July 13 at 10:31 PMTheseus Pharma Shares Plummet 73% on Discontinued Study, THE-630 Developmentmarketwatch.com - July 13 at 5:30 PMTheseus Pharmaceuticals Shares Halted, News Pendingbenzinga.com - July 13 at 5:30 PM Get Theseus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for THRX and its competitors with MarketBeat's FREE daily newsletter. Email Address The Hard Truth About Investing For Retirement (Ad)Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading. Click To Access This Powerful Training Right Now! THRX Media Mentions By Week THRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. THRX News Sentiment▼0.000.32▲Average Medical News Sentiment THRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. THRX Articles This Week▼01▲THRX Articles Average Week Get Theseus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for THRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NGM News KNTE News OMER News MASS News KOD News INMB News DRTS News CADL News SKYE News JYNT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:THRX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theseus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
